COMMONWEALTH EQUITY SERVICES, LLC

Position in ZNTL — Zentalis Pharmaceuticals, Inc.

CIK 312272 WALTHAM, MA

Position in ZNTL

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$143,704

+$60,798 QoQ

Shares Held

61,412

0.0% QoQ

Ownership

0.086%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Healthcare · as of Mar 31, 2026

COMMONWEALTH EQUITY SERVICES, LLC holds $113,564,491 across 120 Biotechnology names. ZNTL ranks #74 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	54,972	$24,547,196
2	REGN	Regeneron Pharmaceuticals, Inc.	16,385	$12,659,706
3	EXEL	Exelixis, Inc.	173,762	$7,452,652
4	TGTX	Tg Therapeutics, Inc.	180,285	$5,989,067
5	TARS	Tarsus Pharmaceuticals, Inc.	80,892	$5,674,573
6	CRSP	CRISPR Therapeutics AG	78,488	$3,733,674
7	ALNY	Alnylam Pharmaceuticals, Inc.	10,577	$3,499,611
8	ARWR	Arrowhead Pharmaceuticals, Inc.	55,076	$3,453,265

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$143,704	61,412	0.0%	Shares	Sole	2026-04-27
2025-12-31	$82,906	61,412	+0.7%	Shares	Sole	2026-02-12
2025-09-30	$92,090	60,987	0.0%	Shares	Sole	2025-10-22
2025-06-30	$70,744	60,987	+0.5%	Shares	Sole	2025-08-06
2025-03-31	$96,492	60,687	-5.1%	Shares	Sole	2025-05-09
2024-12-31	$193,753	63,945	0.0%	Shares	Sole	2025-02-10
2024-09-30	$235,317	63,945	+5.4%	Shares	Sole	2024-10-18
2024-06-30	$248,242	60,695	-0.3%	Shares	Sole	2024-07-31
2024-03-31	$959,705	60,895	+12.2%	Shares	Sole	2024-04-29
2023-12-31	$821,963	54,255	+219.5%	Shares	Sole	2024-02-06
2023-09-30	$340,618	16,980	+65.7%	Shares	Sole	2023-10-23
2023-06-30	$289,152	10,250	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.